Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,855.00    160.00 (2.39%)
Bid:
6,850.00
Ask:
6,865.00
Spread: 15.00 (0.219%)
Market Cap: £5.06b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2012 07:00

RNS Number : 4867Q
Spirax-Sarco Engineering PLC
07 November 2012
 



News Release

 

Wednesday 7th November 2012

INTERIM MANAGEMENT STATEMENT

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st July 2012 to 6th November 2012.

 

Trading

In the four months ended 31st October, organic sales increased 6%, ahead of the rate of growth reported in the first half year. Notably, Asia Pacific and Watson-Marlow achieved strong double-digit sales growth in the period, followed by a more modest advance in the Americas and slightly reduced sales in our Europe, Middle East and Africa (EMEA) segment. Sales in sterling were ahead 2% in the first ten months of 2012, after including the impact of unfavourable currency movements and two small disposals last year.

 

As anticipated, our trading performance in the four months ended 31st October improved with operating profit 8% ahead at constant currency. Better results were particularly evident in Watson-Marlow, where the planned increases in R&D and market development costs in the first half year are unwinding in the second half. Results also improved in EMEA, as the cost base in Europe is being progressively lowered and the profitability of our Supply operations increased. For the ten months ended 31st October 2012, operating profit was therefore 2% ahead of last year at constant currency, compared with a decline of 3% for the first half year.

 

Financial position

We continue to operate with a strong balance sheet and are steadily reducing and rebalancing our stock position in Europe, although this continues to have a negative impact on the factory loading in our main manufacturing plants in the UK and France. Net cash balances at the end of October 2012 increased to £43m compared with £9m at 30th June 2012, although the interim dividend of £12m will be paid on 9th November. There were no significant events or transactions during the period that resulted in a material impact on the financial position of the Group. The principal risks and uncertainties remain those set out on pages 26 and 27 of the 2011 Annual Report.

 

Outlook

Global macro-economic conditions have weakened in recent months as reflected in slowing rates of GDP growth and industrial output in most geographic regions. Trading conditions in many of our markets have, however, remained more resilient and we have not seen softening in underlying demand. The Group has a favourable weighting to defensive industries such as food & beverage, pharmaceuticals and health care, and maintenance spending by our customers has continued to be positive, even against the deterioration in economic conditions.

 

Our business has other resilient characteristics due to our diverse geographic, industry, customer and product spread, and the large proportion of our sales that derive from maintenance or operating spend by our customers. We are seeing the improvements in our Supply organisation from the site consolidation in the UK and from the previously announced cost reduction programme in Europe, which should be complete by the year-end.

 

Although our forward visibility remains short and we are not immune to a worsening in our markets, which can be reflected fairly quickly in our mid-cycle business, the Board continues to expect the Group to make progress for the full year.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

Note

All references above are to adjusted trading results that exclude non-operational items, including the previous announced restructuring costs, amortisation of acquisition-related intangible assets and acquisition and disposal costs.

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBUGGBGDL
Date   Source Headline
4th Sep 201910:00 amRNSBoard Change
21st Aug 20192:49 pmRNSHolding(s) in Company
14th Aug 20199:02 amRNSHolding(s) in Company
9th Aug 201910:27 amRNSDirector/PDMR Shareholding
8th Aug 20194:26 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20195:41 pmRNSChange of Adviser
28th May 20193:08 pmRNSHolding(s) in Company
17th May 20194:16 pmRNSDirector/PDMR Shareholding
16th May 20194:12 pmRNSHolding(s) in Company
15th May 20195:14 pmRNSResult of AGM
15th May 20197:05 amRNSBoard Changes
15th May 20197:00 amRNSAGM Statement - Trading Update
13th May 20192:45 pmRNSCompletion of Acquisition
30th Apr 20199:21 amRNSChange of Director Details
25th Apr 20198:28 amRNSChange of Director Details
11th Apr 20192:36 pmRNSDirector/PDMR Shareholding
15th Mar 201911:25 amRNSAcquisition
7th Mar 20197:00 amRNSFinal Results
1st Mar 20193:04 pmRNSBoard Appointment
18th Feb 20197:00 amRNSExclusive negotiations to acquire Thermocoax
16th Jan 20194:20 pmRNSChange of Director Details
3rd Dec 20187:00 amRNSDisposal
15th Nov 20187:00 amRNSTrading Update
31st Oct 20184:23 pmRNSDirector/PDMR Shareholding
12th Oct 20185:34 pmRNSDirector/PDMR Shareholding
26th Sep 20187:30 amRNSChange of Director Details
20th Sep 201811:16 amRNSHolding(s) in Company
23rd Aug 20184:55 pmRNSHolding(s) in Company
9th Aug 20183:07 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSHalf Year Results
31st Jul 201810:22 amRNSHolding(s) in Company
25th Jul 20189:46 amRNSChange of Director Details
20th Jul 201810:00 amRNSExecutive Director Promotion
11th Jun 20184:26 pmRNSHolding(s) in Company
31st May 20188:12 amRNSDirector/PDMR Shareholding
17th May 20189:26 amRNSDirector/PDMR Shareholding
15th May 20184:55 pmRNSResult of AGM
15th May 20187:00 amRNSAGM Statement - Trading Update
25th Apr 20184:27 pmRNSDirector/PDMR Shareholding
6th Apr 20183:32 pmRNSDirector/PDMR Shareholding
4th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 20184:24 pmRNSTotal Voting Rights
29th Mar 20184:20 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNS2017 Preliminary Results
6th Mar 20187:00 amRNSBoard Appointment
14th Feb 20187:00 amRNSBoard Succession Changes
6th Feb 20187:30 amRNSChange of Director Details
20th Dec 20179:07 amRNSChange of Director Details
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.